(Registrieren)

EANS-Adhoc: LifeWatch AG to report on - Second Quarter 2011 Results on August 23, 2011

Geschrieben am 09-08-2011

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

quarterly report

09.08.2011

- Press release, Letter to Shareholders and Presentation visuals
available at 07:00 a.m. CEST (01:00 EDT) - International Conference
Call / Audio webcast at 10:00 a.m. CEST (04:00 EDT)

Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss
Exchange: LIFE) will report on its results for the second quarter
2011 on Tuesday, August 23, 2011. The company will publish the
results for the second quarter 2011 in an international press
release, a letter to shareholders and presentation visuals at 07:00
a.m. CEST. All documents will also be available for download in the
Investor Relations section of the LifeWatch Website
www.irlifewatch.com.

International Live Conference Call / Audio web cast at 10:00 a.m.
CEST

At 10:00 a.m. CEST, LifeWatch will also discuss the results in a
conference call which will be accompanied by presentation visuals.
The conference call is also accessible as a webcast in the Investor
Relations section of the LifeWatch Website www.irlifewatch.com where
an archived version will remain available for download.

The local dial-in numbers for the conference call are as follows:
+ 41 (0)91 610 56 00 (Europe)
+ 44 (0)203 059 58 62 (UK)
+ 1 (1)866 291 41 66 (USA - Toll-free)

All participants are requested to dial in at least ten minutes prior
to the call. No PIN is required to access the call.

About LifeWatch AG: LifeWatch AG, headquartered in Neuhausen am
Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is
the leading healthcare technology and solution company, specializing
in advanced telehealth systems and wireless remote patient monitoring
services. LifeWatch services cater to individuals, ranging from
high-risk and chronically ill patients, to consumers of health and
wellness products. LifeWatch has subsidiaries in the United States,
the Netherlands, Japan, the United Kingdom, Switzerland and Israel.
LifeWatch AG is the parent company of LifeWatch Services Inc., a
leading US-based cardiac monitoring service provider, and
manufacturer of telecardiology products. LifeWatch is also
introducing a new program for Home Sleep Testing of Obstructive Sleep
Apnea (OSA) patients under the brand name NiteWatch. For additional
information, please visit www.lifewatch.com und
www.nitewatchservices.com.

Sign-up for customized E-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward-looking statements. The
words "believe," "may," "will," "estimate," "continue," "anticipate,"
"intend," "expect" and similar expressions are intended to identify
forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward-looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at the
time of the issue of this press release. LifeWatch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

Further inquiry note:
For further information please contact:
Sensus Investor and Public Relations, Zürich:
Tel +41 43 366 55 11
Fax +41 43 366 55 12
Email lifewatch@sensus.ch

end of announcement euro adhoc
--------------------------------------------------------------------------------

issuer: LifeWatch AG
Rundbuckstrasse 6
CH-8212 Neuhausen am Rheinfall
phone: +41 52 632 00 50
FAX: +41 52 632 00 51
mail: users@lifewatch.com
WWW: www.lifewatch.com
sector: Healthcare Providers
ISIN: CH0012815459
indexes: SPI, SPIEX
stockmarkets: Open Market / XETRA: Frankfurt, free trade: Berlin, Main Standard:
SIX Swiss Exchange
language: English


Kontaktinformationen:

Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.

Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.

Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.

http://www.bankkaufmann.com/topics.html

Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.

@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf

E-Mail: media(at)at-symbol.de

346251

weitere Artikel:
  • EANS-Adhoc: LifeWatch AG gibt Resultate für das zweite Quartal 2011 am 23. August 2011 bekannt -------------------------------------------------------------------------------- Ad-hoc-Mitteilung übermittelt durch euro adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich. -------------------------------------------------------------------------------- Quartalsbericht 09.08.2011 - Pressemitteilung, Aktionärsbrief und Präsentationsfolien um 07.00 Uhr MESZ - Internationale Telefonkonferenz / Audio Webcast um 10.00 Uhr MESZ Neuhausen am Rheinfall / Schweiz - LifeWatch AG (SIX mehr...

  • Heidelberger Druckmaschinen AG: Geschäftsjahr 2011/12: Heidelberg veröffentlicht Zahlen für das erste Quartal - operatives Ergebnis verbessert Heidelberg (ots) - - Auftragseingang mit 665 Mio. Euro im Rahmen der Erwartungen - Umsatz mit 544 Mio. Euro währungsbereinigt auf Vorjahresniveau - Auftragsbestand auf 718 Mio. Euro angestiegen - Ergebnis der betrieblichen Tätigkeit verbessert sich auf minus 25 Mio. Euro (Vorjahr: minus 35 Mio. Euro) - Nettofinanzverschuldung mit 260 Mio. Euro im Vergleich zum Vorjahr deutlich reduziert - Ausblick 2011/12: Weiterhin ausgeglichenes Vorsteuerergebnis angestrebt - Auswirkung der Schuldenkrise auf Weltwirtschaft mehr...

  • EANS-News: SYGNIS Pharma AG / SYGNIS schließt Patientenrekrutierung der AXIS 2-Studie erfolgreich ab -------------------------------------------------------------------------------- Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der Emittent/Meldungsgeber verantwortlich. -------------------------------------------------------------------------------- Forschung/Entwicklung Heidelberg (euro adhoc) - SYGNIS schließt Patientenrekrutierung der AXIS 2-Studie erfolgreich ab • 328 Patienten in ca. 80 Schlaganfallzentren und acht Ländern eingebunden • AX200 ist einer der weltweit am weitesten entwickelten mehr...

  • EANS-News: SYGNIS Pharma AG / SYGNIS successfully completes patient recruitment for AXIS 2 Study -------------------------------------------------------------------------------- Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Research & Development Heidelberg (euro adhoc) - SYGNIS successfully completes patient recruitment for AXIS 2 Study • 328 patients recruited at about 80 stroke centres in eight European countries • AX200 is one of the most advanced drug mehr...

  • EANS-News: ANDRITZ-GRUPPE: Erfreuliche Geschäftsentwicklung im 2. Quartal 2011 -------------------------------------------------------------------------------- Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der Emittent/Meldungsgeber verantwortlich. -------------------------------------------------------------------------------- 6-Monatsbericht Graz (euro adhoc) - Graz, 9. August 2011. Der internationale Technologiekonzern ANDRITZ verzeichnete im 2. Quartal 2011 eine erfreuliche Geschäftsentwicklung und konnte alle relevanten Kennzahlen im Jahresvergleich steigern. - Der Umsatz der mehr...

Mehr zu dem Thema Finanzen

Der meistgelesene Artikel zu dem Thema:

Century Casinos wurde in Russell 2000 Index aufgenommen

durchschnittliche Punktzahl: 0
Stimmen: 0

Bitte nehmen Sie sich einen Augenblick Zeit, diesen Artikel zu bewerten:

Exzellent
Sehr gut
gut
normal
schlecht